issues. In this review, I will examine the nature and characteristics of the chromosomal fragile sites with an emphasis on those sites that are heritable, the current theories regarding the mechanism(s) of fragile site formation, the correlation of fragile site location with the chromosomal breakpoints in the nonrandom abnormalities noted in human tumors, and the gaps in our current understanding of the role of fragile sites in the pathogenesis of human tumors.
HISTORICAL ASPECTS
The first report of a fragile site was published in I 965 by Dekaban who described a persisting clone of cells with an abnormal C group chromosome in a woman who had received radiation therapy.' Three years later, Lejeune et at demonstrated that these sites were heritable when they described a fragile site on the long arm of chromosome 2 in a woman and her daughter.2
The chromosomal fragile site at Xq27, now known as the fragile X, was first described by Lubs in 1969 in association with mental retardation.3 In the following years, it became clear that the fragile X chromosome is associated with, if not the cause of, one form of X-linked mental retardation in both males and females.4
The heritable chromosomal fragile sites were defined by Sutherland5'6 as specific points or loci that show the following features:
(1) the chromosome has a nonstaining gap of variable width that usually involves both chromatids; For 
